Maintenance treatment of patients with healed reflux esophagitis, comparing remission rates during 6 months with esomeprazole 20 mg q.d. and lansoprazole 15 mg q.d. - A randomised, double-blind multi-centre study - METROPOLE
Study identifier:SH-QBE-0067
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Maintenance treatment of patients with healed reflux esophagitis, comparing remission rates during 6 months with esomeprazole 20 mg q.d. and lansoprazole 15 mg q.d. - A randomised, double-blind multi-centre study - METROPOLE
Medical condition
gastrointestinal diseases
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 May 2000
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
